In a four month trial of 39 adults, both groups regained about 3.6% of body weight versus 10.75% with usual care. Researchers say larger, longer studies are needed.
Recap by typeshit. Full story at Healthline.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
A case study describes a rare but life-threatening complication linked to weight loss medications. Full details are in the NewsNation report.
The Medlines hosts go over trial data showing average weight loss of up to 28.3% at 80 weeks, alongside other medical news of the day.
Loading…